Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
19 hedge funds and large institutions have $64.9M invested in Zosano Pharma Corporation in 2015 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$23.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.7M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.88M |
| 4 |
BC
Broadfin Capital
New York
|
+$5.2M |
| 5 |
VAM
Visium Asset Management
New York
|
+$4.82M |
Top Sellers
ZSAN Hedge Fund Activity: Q1 2015 in Review
19 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2015, worth a combined $64.9M.
Buyers outnumbered sellers: 19 funds opened new ZSAN positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $23.1M.
- 19 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2015, up from 0 in Q4 2014.
- Funds reported $64.9M of Zosano Pharma Corporation stock for Q1 2015.
- 19 funds opened new Zosano Pharma Corporation positions in Q1 2015 and 0 closed out, a net change of +19 holders.
- The largest Zosano Pharma Corporation buyer in Q1 2015 was NEA Management Company, an estimated $23.1M added.
Based on aggregated 13F filings for Q1 2015.